Experimental Reptarenavirus Infection of Boa constrictor and Python regius
U Hetzel1,2, Y Korzyukov3, S Keller1
1Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
Journal of Virology
|January 14, 2021
Summary
Reptarenavirus experimentally infected pythons and boas, causing persistent infection but not inclusion body disease (IBD). Vaccination showed promise against homologous virus challenge, suggesting potential for BIBD prevention in snakes.
Area of Science:
- Veterinary Virology
- Herpetology
- Infectious Diseases
Background:
- Boid inclusion body disease (BIBD) is a significant global threat to captive snakes, characterized by cytoplasmic inclusion bodies (IBs) primarily composed of reptarenavirus nucleoprotein (NP).
- Previous research established a causative link between reptarenavirus infection and BIBD by reproducing the disease in boas and pythons.
Purpose of the Study:
- To experimentally infect Ball pythons (Python regius) and Boa constrictors (Boa constrictor) with reptarenavirus isolates.
- To investigate the efficacy of different virus delivery routes (intraperitoneal injection, tracheal instillation) and vaccination strategies.
- To develop an animal model for studying BIBD transmission and pathogenesis, and to compare antibody responses between experimental and natural infections.
Main Methods:
- Experimental infection of pythons (n=16) and boas (n=16) with three reptarenavirus isolates using intraperitoneal injection and tracheal instillation.
- Monitoring for clinical signs, viral RNA detection, and inclusion body formation over several months.
- Testing vaccination efficacy using recombinant protein or inactivated virus preparations, followed by homologous and heterologous virus challenge.
Main Results:
- Tracheal instillation and intraperitoneal injection led to reptarenavirus infection in pythons, with transient central nervous system signs observed in some individuals.
- Experimental infections did not result in the formation of characteristic inclusion bodies (IBs) in either pythons or boas.
- Boas developed persistent reptarenavirus infections (11/12) lasting at least 10 months post-inoculation.
- Vaccination protected three of four snakes against homologous virus challenge, but not against heterologous virus challenge.
- Differences were observed in antibody responses between experimentally and naturally infected snakes.
Conclusions:
- Experimental reptarenavirus infection can be established in pythons and boas via multiple routes, with tracheal instillation potentially mimicking natural infection.
- The absence of inclusion bodies in experimentally infected snakes suggests that BIBD pathogenesis is complex and may require additional factors beyond initial infection.
- Vaccination strategies show potential for controlling homologous reptarenavirus infections, warranting further investigation for BIBD prevention.


